COMPASS Pathways' key patents upheld by the US Patent and Trademark Office
06 juin 2023 08h00 HE
|
COMPASS Pathways
PTAB rejects two requests for rehearing of the USPTO's decision denying institution of post-grant review (PGR) of U.S. patent numbers 10,947,257 (‘257 Patent) and 10,954,259 (‘259 Patent).In June...
COMPASS Pathways’ Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer
31 mai 2023 08h30 HE
|
COMPASS Pathways
LONDON, May 31, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation, today...
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
26 mai 2023 16h00 HE
|
COMPASS Pathways
LONDON, May 26, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023
26 mai 2023 07h00 HE
|
COMPASS Pathways
More than half of the patients demonstrated remission of depression at 18 months, after a single dose of 25mg investigational COMP360 psilocybin with psychological supportOpen label phase 2 study,...
COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights
11 mai 2023 07h00 HE
|
COMPASS Pathways
LONDON, May 11, 2023 (GLOBE NEWSWIRE) -- Highlights: COMP360 Phase 3 pivotal program underway, patients have been treated in both trialsCPT® III code for in-person psychedelic therapy support...
COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023
03 mai 2023 16h01 HE
|
COMPASS Pathways
LONDON, May 03, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
American Medical Association to Issue First New Code for Psychedelic Therapies
02 mai 2023 07h00 HE
|
COMPASS Pathways | MAPS Public Benefit Corporation
LONDON and SAN JOSE, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based...
COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference
10 avr. 2023 10h10 HE
|
COMPASS Pathways
LONDON, April 10, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
COMPASS Pathways to participate in upcoming Cowen 43rd Annual Health Care Conference, Oppenheimer 33rd Annual Healthcare Conference, and Loop Capital Investor Conference
02 mars 2023 10h23 HE
|
COMPASS Pathways
LONDON, March 02, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results and Business Highlights
28 févr. 2023 07h00 HE
|
COMPASS Pathways
Highlights: Phase 3 pivotal program underway - important updates announcedPhase 3 long term follow up definedCash position at 31 December 2022 of $143.2 millionConference call today at 8:00am ET...